Hui Miao
Director/Board Member at Beijing Zhendong Langdi Pharmaceutical Co., Ltd.
Hui Miao active positions
Companies | Position | Start | End |
---|---|---|---|
Beijing Zhendong Langdi Pharmaceutical Co., Ltd.
Beijing Zhendong Langdi Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Part of Fountainvest Partners (Asia) Ltd., Beijing Zhendong Langdi Pharmaceutical Co., Ltd. manufactures medicinal chemicals and botanical products. The company is based in Beijing, China. Beijing Zhendong Langdi Pharmaceutical Co. was acquired by Shanghai Fanglang Enterprise Management Co. Ltd. from Shanxi Zhendong Pharmaceutical Co., Ltd. on October 28, 2021 for $895.09 million. The Chinese company was founded in 2003. | Director/Board Member | - | - |
Career history of Hui Miao
Former positions of Hui Miao
Companies | Position | Start | End |
---|---|---|---|
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. | Director/Board Member | 2022-10-16 | 2024-04-08 |
Chief Executive Officer | 2022-06-30 | 2024-04-08 | |
Corporate Officer/Principal | 2022-06-30 | 2022-09-22 | |
President | 2022-09-22 | 2024-04-08 |
Training of Hui Miao
Renmin University of China | Undergraduate Degree |
Statistics
International
China | 4 |
Operational
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. | Health Technology |
Private companies | 1 |
---|---|
Beijing Zhendong Langdi Pharmaceutical Co., Ltd.
Beijing Zhendong Langdi Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Part of Fountainvest Partners (Asia) Ltd., Beijing Zhendong Langdi Pharmaceutical Co., Ltd. manufactures medicinal chemicals and botanical products. The company is based in Beijing, China. Beijing Zhendong Langdi Pharmaceutical Co. was acquired by Shanghai Fanglang Enterprise Management Co. Ltd. from Shanxi Zhendong Pharmaceutical Co., Ltd. on October 28, 2021 for $895.09 million. The Chinese company was founded in 2003. | Health Technology |
- Stock Market
- Insiders
- Hui Miao
- Experience